VIVES is a multi-sector fund that invests in projects with a positive societal impact
CISSOID is the leader in high temperature semiconductor solutions, delivering standard products and custom solutions for power management, power conversion and signal conditioning in extreme...
To meet the growing demand for agricultural production, traditional production methods will have to be complemented by new technologies that not only improve crop yields, but also increase their...
Promethera Biosciences’ mission is to bring patients life-saving treatments to reduce the need for liver transplantation. The company is pioneering the development of cell-based therapies that provide...
Pierre Blondeau, CEO Upstreem :
"We have been working since 2017 with VIVES II, which has joined us since the beginning of our adventure. VIVES II team has an in-depth understanding of all aspects of...
Pierre-Antoine Mariage, co-CEO Botalys :
"VIVES trusted us at an early stage. In addition to their financial investment, they offer us a regular and wise coaching from their experts while respecting...
Chris Buyse, Co founder and Managing Partner of Fund+ :
"Fund+ is impressed by the outstanding scientific achievements of our Belgian universities and therefore supports and invests in its innovative...
March 31, 2021 - Louvain-la-Neuve, Belgium: Tessares - a technology company specializing in Hybrid Access software - has just concluded a new round of funding to fast forward an innovative software
LEUVEN, Belgium, March 22nd, 2021 — ViroVet NV, a leading Belgian biopharmaceutical company active in the development of innovative vaccines and antiviral drugs for livestock, is proud to announce
Vaccines alone are not enough to fight Covid-19. Experts pinpointed during several occasions on the importance of having antibody-based treatments available in combination with vaccines.
This is